While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.
NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.
NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.
BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.
Olink Bioscience this week appointed Simon Fredriksson as its new president and CEO, replacing Bjorn Ekstrom, who has led the company since its founding in 2004 and will be joining its board of directors.
According to CEO Hubert Koster, the financing will allow the company to expand its Capture Compound Mass Spectrometry technology into additional markets and "execute several large pharma partnerships at the same time."
Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.
